PUBLICATIONS 2024 Boilève A, Ducreux M, Jaulin F. Reply. Gastroenterology. 2025;168(3):628-630. doi:10.1053/j.gastro.2024.11.005 Boilève A, Cartry J, Goudarzi N, et al. Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer. Gastroenterology. 2024;167(5):961-976.e13. doi:10.1053/j.gastro.2024.05.032 Boilève A., Rousseau A., Hilmi A., et al. Codon-specific KRAS mutations predict survival in advanced pancreatic cancer. Volume 3, 100030, March 2024 Boilève A, Smolenschi C, Lambert A, et al. KRAS, a New Target for Precision Medicine in Colorectal Cancer?. Cancers (Basel). 2024;16(20):3455. Published 2024 Oct 12. doi:10.3390/cancers16203455 Ben-Ammar I, Rousseau A, Nicolle R, et al. Precision medicine for KRAS wild-type pancreatic adenocarcinomas. Eur J Cancer. 2024;197:113497. doi:10.1016/j.ejca.2023.113497 Boileve A, Smolenschi C, Lambert A, et al. Role of molecular biology in the management of pancreatic cancer. World J Gastrointest Oncol. 2024;16(7):2902-2914. doi:10.4251/wjgo.v16.i7.2902 Pasquier N, Jaulin F, Peglion F. Inverted apicobasal polarity in health and disease. J Cell Sci. 2024;137(5):jcs261659. doi:10.1242/jcs.261659 Bonnet V, Maikranz E, Madec M, et al. Cancer-on-a-chip model shows that the adenomatous polyposis coli mutation impairs T cell engagement and killing of cancer spheroids. Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2316500121. doi: 10.1073/pnas.2316500121. Epub 2024 Mar 5. PMID: 38442157. 2023 Jérôme Cartry, Sabrina Bedja, Alice Boilève, Jacques R. R. Mathieu, Emilie Gontran, Maxime Annereau, Bastien Job, Ali Mouawia, Pierre Mathias, Thierry De Baère, Antoine Italiano, Benjamin Besse, Isabelle Sourrouille, Maximiliano Gelli, Mohamed-Amine Bani, Peggy Dartigues, Antoine Hollebecque, Cristina Smolenschi, Michel Ducreux, David Malka & Fanny Jaulin. Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer. J Exp Clin Cancer Res. 2023 Oct 25;42(1):281.
